Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2025-12-25 @ 12:02 AM
NCT ID: NCT02177058
Eligibility Criteria: Inclusion Criteria: * \> 40 Beds * MD, NP or PA available on-site at least 1/week * Capable of Starting intravenous fluids * Capable of Providing respiratory treatments * Capable of Assessing oxygenation status by pulse oximetry * \< 4 hrs turnaround time for STAT medications ("stat" is an abbreviation of the Latin word statim, meaning "immediately, without delay") * \< 8 hrs. turnaround time for STAT laboratory tests * \< 8 hrs. turnaround time for STAT X-rays * Computers available for online staff training * Strong support for participation from the facility administrator, director of nursing, and medical director, as well as corporate leadership (for NHs that are part of a corporate chain), as evidenced by a signed agreement before enrollment * \> 10% 30-day readmission rates Exclusion Criteria: * Hospital based * Having only private pay residents (no Medicare/Medicaid, no Medicare provider number). * Participation in a project designed specifically to reduce acute care transfers or hospitalization rates (including federal demonstrations) * Conducting more than one other major quality improvement or research project during the project period which would threaten their ability to fully participate in the trial. * Specialize in Pediatrics (\> 30 % of patients in NHs are pediatric) * Specialize in HIV (\> 30 % of patients in NHs are HIV) * Specialize in Respiratory care with ventilator care (\>30% of patients in NH are in this category) * Robust INTERACT implementation and/or very low hospitalization rate * Located in a country outside USA
Healthy Volunteers: False
Sex: ALL
Study: NCT02177058
Study Brief:
Protocol Section: NCT02177058